22 studies found for:    "glucose-6-phosphate dehydrogenase deficiency"
Show Display Options
Rank Status Study
1 Enrolling by invitation Comparing G6PD Tests Using Capillary Blood Versus Venous Blood
Condition: Glucose-6 Phosphate Dehydrogenase Deficiency
Intervention: Other: G6PD Test
2 Recruiting Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
Conditions: G6PD Normal;   G6PD Deficient;   Healthy
Intervention: Drug: Regimens (Primaquine, Methylene blue)
3 Completed Evaluation of Different G6PD Testing Platforms
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention:
4 Completed A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Favism
Intervention: Drug: Primaquine
5 Not yet recruiting Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention: Dietary Supplement: non- fava beans
6 Completed Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Hyperbilirubinemia;   Hemolytic Disease of Newborn
Intervention: Drug: tin mesoporphyrin
7 Recruiting Safety and Tolerability of Low Dose Primaquine
Conditions: Malaria, Falciparum;   G6PD Deficiency
Interventions: Drug: Dihydroartemisinin piperaquine (DHA PP);   Drug: Primaquine
8 Completed G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine;   Drug: Tafenoquine
9 Completed Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
Condition: Acne Vulgaris
Interventions: Drug: ACZONE Gel, 5%;   Drug: Vehicle
10 Unknown  Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
Conditions: Diabetes;   Obesity
Intervention:
11 Recruiting Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Condition: Malaria
Interventions: Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine
12 Completed A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh
Condition: Malaria
Interventions: Drug: chloroquine;   Drug: Artemether-lumefantrine combination;   Drug: Primaquine
13 Completed Examination of Protective Factors Against Severe Malaria
Conditions: Malaria;   Severe Malaria
Intervention:
14 Recruiting Primaquine Pharmacokinetics in Lactating Women and Their Infants
Condition: Vivax Malaria
Intervention: Drug: Primaquine
15 Completed Collection of Blood From Persons With Hemoglobin and Erythrocyte Polymorphisms for Laboratory Malaria Research
Conditions: Hemoglobin Mutations;   Erythrocyte Variants
Intervention:
16 Recruiting Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With Hyperbilirubinemia
Conditions: Jaundice, Neonatal;   Hyperbilirubinemia, Neonatal
Interventions: Drug: stannsoporfin;   Drug: Placebo
17 Completed Innate and Acquired Resistance to Plasmodium Falciparum Malaria in Mali
Condition: Malaria
Intervention:
18 Completed Malaria Studies in Cambodia
Condition: Malaria
Intervention:
19 Completed Demographic, Metabolic, and Genomic Description of Neonates With Severe Hyperbilirubinemia
Conditions: Hyperbilirubinemia;   Jaundice
Intervention: Procedure: Gene mutation sample
20 Completed Lapdap and Coartemether for Uncomplicated Malaria
Condition: Malaria
Interventions: Drug: Chlorproguanil-dapsone (Lapdap);   Drug: Lumefantrine-artemether (Coartemether )

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years